On Demand Webinars
Assessing the application of standardized processes in cell and gene therapy development and manufacturing.
As the cell and gene therapy (CGT) field evolves, standardized processes have emerged as a popular method to accelerate development timelines, reduce costs, and improve scalability, all contributing to faster patient access to breakthrough therapies.
Enhancing Next-Gen Antibody Therapies: Advanced Strategies for Fcγ Receptor Binding Assays in Antibody Research
The webinar provides a detailed overview of the considerations and guidelines for conducting Fcγ receptor binding studies, particularly for IgG1, IgG2, and IgG4 monoclonal antibodies.
The science of Container Closure: Headspace Gas Ingress Methods as the Golden Tool
It has become generally accepted that headspace gas ingress methods represent the most robust and flexible approaches for performing container closure integrity (CCI) testing throughout the product life cycle.
Pave Your Weigh to Accurate Analytical Results
This webinar, led by Jim Palmer from Sartorius, Highlights the crucial role of lab balances in ensuring accurate analytical results.
Opportunities for innovation and flexibility in mRNA and LNP manufacturing
From global vaccines to personalized cancer therapies, mRNA is being considered for a variety of clinical applications, creating varying requirements for production scale and dosage.
Converging Innovations to Break Barriers in Neural Drug Discovery
RealBrain® microtissues, a family of class-leading 3D organotypic neural models, offer human-relevant alternatives to traditional animal models for high-throughput screening of potential drug candidates.
Innovative AI-Driven Solutions to Address the Growing Complexity of APIs
The complexity of small molecule active pharmaceutical ingredients (APIs) is rising, bringing longer syntheses that challenge innovators' timely readiness for the Clinic.
The road to commercial readiness: Mastering API production at every scale
Mastering the complexities of active pharmaceutical ingredient (API) commercial production is crucial for ensuring the consistent quality, efficacy, and safety of pharmaceutical products.
